Today, the Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, applauded the Food and Drug Administration (FDA) for implementing a new blood donation policy that moves to an individual donor assessment rather than restrictions based on sexual orientation. While this is a critical step in the right direction, further investment in technologies and research – such as technology to reduce pathogens in red blood cells currently in Phase III Clinical Trials – is needed to enable even more individuals to donate whole blood. In a recent HRC survey, nearly 90 percent of respondents believe the federal government needs to “prioritize investing in more technologies and research to allow more people to donate blood.” The technology exists today to prevent transmission of certain pathogens such as HIV in plasma and platelets.
To make a general inquiry, please visit our contact page. Members of the media can reach our press office at: (202) 572-8968 or email firstname.lastname@example.org.